Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells

SIMPLE SUMMARY: In this study, we developed human platelet lysate-induced antigen-presenting cells (HPL-APCs) from peripheral monocytes with a high potency of presentation ability. This study aimed to verify the safety, tolerability, and immunoinducibility of HPL-APCs loaded with cancer candidate an...

Descripción completa

Detalles Bibliográficos
Autores principales: Koya, Terutsugu, Yoshida, Kenichi, Togi, Misa, Niida, Yo, Togi, Sumihito, Ura, Hiroki, Mizuta, Shuichi, Kato, Tomohisa, Yamada, Sohsuke, Shibata, Takeo, Liu, Yi-Chang, Yuan, Shyng-Shiou, Wu, Deng-Chyang, Kobayashi, Hirohito, Utsugisawa, Taiju, Kanno, Hitoshi, Shimodaira, Shigetaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377585/
https://www.ncbi.nlm.nih.gov/pubmed/37509288
http://dx.doi.org/10.3390/cancers15143627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377585/
https://www.ncbi.nlm.nih.gov/pubmed/37509288
http://dx.doi.org/10.3390/cancers15143627

Ejemplares similares